Altered Immune Regulation in Type 1 Diabetes
Research in genetics and immunology was going on separate strands for a long time. Type 1 diabetes mellitus might not be characterized with a single pathogenetic factor. It develops when a susceptible individual is exposed to potential triggers in a given sequence and timeframe that eventually disar...
Main Authors: | András Zóka, Györgyi Műzes, Anikó Somogyi, Tímea Varga, Barbara Szémán, Zahra Al-Aissa, Orsolya Hadarits, Gábor Firneisz |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Clinical and Developmental Immunology |
Online Access: | http://dx.doi.org/10.1155/2013/254874 |
Similar Items
-
Reduced GLP-1 response to a meal is associated with the CTLA4 rs3087243 G/G genotype
by: András Zóka, et al.
Published: (2019-09-01) -
The <i>MTNR1B</i> rs10830963 Variant in Interaction with Pre-Pregnancy BMI is a Pharmacogenetic Marker for the Initiation of Antenatal Insulin Therapy in Gestational Diabetes Mellitus
by: Gábor Firneisz, et al.
Published: (2018-11-01) -
Association Study with 77 SNPs Confirms the Robust Role for the rs10830963/G of MTNR1B Variant and Identifies Two Novel Associations in Gestational Diabetes Mellitus Development.
by: Klara Rosta, et al.
Published: (2017-01-01) -
Identification and Potential Clinical Utility of the MTNR1B rs10830963 Core Gene Variant Associated to Endophenotypes in Gestational Diabetes Mellitus
by: Gábor Firneisz, et al.
Published: (2020-04-01) -
Serum dipeptidyl peptidase-4 activity in insulin resistant patients with non-alcoholic fatty liver disease: a novel liver disease biomarker.
by: Gábor Firneisz, et al.
Published: (2010-01-01)